Literature DB >> 6420696

Human lymphocytes treated with r-7,t-8-dihydroxy-t-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene require low-density lipoproteins for DNA excision repair.

C O Joe, P W Rankin, D L Busbee.   

Abstract

Human lymphocytes which were non-mitogen-stimulated, and which were depleted of lipoproteins, were found to be deficient in DNA excision repair typically initiated in these cells in response to treatment with a direct-acting polynuclear aromatic hydrocarbon carcinogen. Lymphocytes either depleted of lipoproteins or supplemented with human low-density lipoproteins formed DNA-carcinogen adducts which were not chromatographically distinguishable. The state of lipoprotein depletion did not alter lymphocyte uptake of thymidine from the medium. Lymphocytes which were depleted of lipoproteins, treated with carcinogen, and subsequently supplemented with low-density lipoproteins, regained the ability to engage in DNA excision repair. The data suggest that either low-density lipoprotein(s), or a component(s) of low-density lipoprotein(s), is required by human lymphocytes in order to initiate excision repair of carcinogen-damaged DNA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420696     DOI: 10.1016/0167-8817(84)90045-2

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Use of scintillometric quantitation of unscheduled DNA synthesis in isolated rat hepatocytes for the screening of genotoxic agents.

Authors:  M T Hsia
Journal:  Cell Biol Toxicol       Date:  1987-06       Impact factor: 6.691

2.  Inhibition of DNA synthesis by an electrophilic metabolite of benzo[a]pyrene.

Authors:  D L Busbee; C O Joe; J O Norman; P W Rankin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  The sesquiterpene lactone hymenoxon acts as a bifunctional alkylating agent.

Authors:  V L Sylvia; H L Kim; J O Norman; D L Busbee
Journal:  Cell Biol Toxicol       Date:  1987-03       Impact factor: 6.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.